LIGAND PHARMACEUTICALS INCORPORATED Proceeds from (Payments for) Other Financing Activities
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Proceeds from (Payments for) Other Financing Activities of -$40.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2023-11-09
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from (payments for) other financing activities for the quarter ending 2023-09-30 was -$14.00K.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from (payments for) other financing activities for the quarter ending 2023-06-30 was -$26.00K, a 127.66% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from (payments for) other financing activities for the quarter ending 2023-03-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from (payments for) other financing activities for the quarter ending 2022-09-30 was -$15.00K.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 6 month as first filed | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 9 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$40.00K derived: sum of 2 quarters · filed 2023-11-09 | -$40.00K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$26.00K 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | ||||
| 2022-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $79.00K derived: sum of 2 quarters · filed 2023-11-09 | -$42.00K 10-Q · filed 2023-11-09 | -$4.17M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$27.00K 10-Q · filed 2023-08-09 | -$206.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | -$121.00K 10-Q · filed 2023-05-08 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | ||||
| 2020-09-30 | -$4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$5.22M 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | -$1.13M 10-Q · filed 2020-08-07 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-07 |